Peptio

Peptides in dermatology research

Peptides studied for skin and hair, keeping topical cosmetic research separate from systemic claims, which are two different literatures.

Dermatology research on peptides splits into two very different literatures: topical cosmetic studies, which are often small and industry-funded, and systemic research, which is sparser. Conflating them is the most common error in this area.

Peptides studied in this area

  • Afamelanotide

    Scenesse, Melanotan I, Melanotan-1, MT-1, CUV1647, NDP-MSH

    A synthetic alpha-MSH analogue approved as an implant for one rare light disease in adults. Melanotan I was a code name; products sold as it are not the drug.

    Human RCTApproved for a medical indicationskin hair / safety regulation
  • GHK-Cu

    copper tripeptide-1, GHK copper, prezatide copper, glycyl-L-histidyl-L-lysine copper

    A three-amino-acid peptide bound to copper, used in skin care. Its human studies are topical; none injected GHK-Cu on its own or tested it systemically.

    Human RCTIn clinical trialsskin hair / safety regulation
  • Melanotan II

    Melanotan 2, Melanotan-II, MT-II, MTII, MT2

    A synthetic cyclic peptide sold for tanning. Its human trials total 23 men between 1996 and 2000, and none of the regulators checked has approved it.

    Case reportIn clinical trialsskin hair / safety regulation

Further reading